1. Home
  2. INVE vs CUE Comparison

INVE vs CUE Comparison

Compare INVE & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Identiv Inc.

INVE

Identiv Inc.

N/A

Current Price

$2.39

Market Cap

65.1M

Sector

Technology

ML Signal

N/A

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

N/A

Current Price

$25.60

Market Cap

233.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INVE
CUE
Founded
1990
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.1M
233.5M
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
INVE
CUE
Price
$2.39
$25.60
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$3.55
★ $88.00
AVG Volume (30 Days)
107.2K
★ 353.1K
Earning Date
11-09-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 61.11
EPS
★ N/A
N/A
Revenue
★ $60,219,000.00
$27,466,000.00
Revenue This Year
$21.08
N/A
Revenue Next Year
$16.10
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
7.21
★ 195.75
52 Week Low
$2.32
$0.17
52 Week High
$5.30
$45.50

Technical Indicators

Market Signals
Indicator
INVE
CUE
Relative Strength Index (RSI) 38.97 42.64
Support Level $2.32 $23.51
Resistance Level $3.03 $33.11
Average True Range (ATR) 0.09 4.91
MACD -0.01 -0.83
Stochastic Oscillator 30.38 11.41

Price Performance

Historical Comparison
INVE
CUE

About INVE Identiv Inc.

Identiv Inc develops specialty radio-frequency identification (RFID) and Internet of Things It (IoT) solutions that address customers' challenges and create new opportunities for them through the digitization and enhanced connectivity to the IoT. It designs, produces, and sells RFID and Bluetooth Low Energy (BLE) enabled devices, RFID inlays, tags, and labels that can be applied or incorporated into physical objects, providing them with a digital identity and the ability for customers to track, monitor, authenticate, and engage with consumers. Its IoT Business segment develops, manufactures, and supplies specialty IoT solutions tailored for the healthcare, logistics, smart packaging industries and other high-value end markets.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

Share on Social Networks: